Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy
- PMID: 29518092
- PMCID: PMC5843213
- DOI: 10.1371/journal.pntd.0006173
Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Maphanga TG, Britz E, Zulu TG, M RS., Naicker SD, Schwartz IS, et al. In vitro antifungal susceptibility of the yeast- and mould-phases of the dimorphic fungal pathogen, Emergomyces africanus (formerly Emmonsia species), from HIV-infected South African patients. J Clin Microbiol. 2017;55: 1812–1820. doi: 10.1128/JCM.02524-16 - DOI - PMC - PubMed
-
- Statistics South Africa. Statistical release P0302 Mid-year population estimates 2017. http://www.statssa.gov.za/publications/P0302/P03022017.pdf. Accessed Jan 1, 2018.
-
- World Health Organisation. Prevent HIV, test and treat all. Progress report 2016. World Health Organization; 2016; 64. http://www.who.int/iris/handle/10665/251713. Accessed Jan 1, 2018.
-
- May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet (London, England). NIH Public Access; 2010;376: 449–57. doi: 10.1016/S0140-6736(10)60666-6 - DOI - PMC - PubMed
-
- Dukik K, Muñoz JF, Jiang Y, Feng P, Sigler L, Stielow JB, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017; doi: 10.1111/myc.12601 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
